Interview | Prof. Dr. Peter Nicholas Robinson "Humboldt Professor for Artificial Intelligence 2024"
Using data for precision medicine
6 Min
More 
A new channel for touch
Touch is a fundamental, yet scarcely understood, sense. Now, the team led by Gary Lewin at the Max Delbrück Center has discovered a second ion channel associated with touch perception. Elkin1 could be a target for pain therapy, the team writes in…
2 Min
More Eckert & Ziegler Extends Ga-68 Activities in Japan
Berlin, Germany – 28 February 2024 – Eckert & Ziegler (ISIN DE0005659700, SDAX) expands its activities on Gallium-68 (Ga-68) labeled diagnostics in Japan together with Novartis Pharma K.K. (Japan).
1 Min
More New Study on the Benefits of Covid-19 Nasal Spray Vaccination Published in “Nature Communications” - Joint research led by scientists at Freie Universität Berlin reaches another milestone
Rocketvax AG, together with the German Research Foundation (DFG), has financially supported a study carried out as part of a joint project of the Swiss National Science Foundation (SNSF, National Research Program “Covid-19,” NRP 78) and the German…
3 Min
More Releasing “brakes” in the brain - Researchers use deep brain stimulation to localize disrupted neural pathways
When certain connections in the brain do not function correctly, disorders such as Parkinson’s disease, dystonia, obsessive-compulsive disorder (OCD), and Tourette’s syndrome may result. Targeted stimulation of specific areas in the brain can help…
5 Min
More How COVID-19 affects the brain - Neurological symptoms apparently not a result of SARS-CoV-2 infection of the brain
Scientists still are not sure how neurological symptoms arise in COVID-19. Is it because SARS-CoV-2 infects the brain? Or are these symptoms the result of inflammation in the rest of the body? A study by Charité – Universitätsmedizin Berlin has now…
4 Min
More Competition call for the Deep Tech Award
Deadline: April 26, 2024
1 Min
More MTIP Invests $15 Million in Caresyntax
MTIP invested $15 million to accelerate Caresyntax's commercial growth and to expand its data-driven surgery platform.
3 Min
More EARLYBIRD HEALTH CLOSES FRESH FUND OF EUR 173M
● The Fund’s focus is on healthcare innovations that improve patient outcomes
● Leveraging Earlybird Eagle Eye, a cutting-edge proprietary AI tool, the Fund
gains deal flow and market intelligence
● Uniquely, the only European fund with public…
2 Min
More FyoniBio collaborates with BioLamina and Alder Therapeutics
FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications
4 Min
More Show more items
